Outcome of Patients Supported by Large Impella Systems After Re-implantation Due to Continued or Recurrent Need of Temporary Mechanical Circulatory Support

Despite the growing utilization of a large microaxial pump, i. e., Impella 5.0 or 5.5 (Abiomed Inc., Danvers, MA, USA) (Impella 5+) for patients with cardiogenic shock (CS), adverse events including the necessity of re-implantation have not been well discussed. In all 67 patients, in-hospital mortal...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugimura, Yukiharu, Bauer, Sebastian, Immohr, Moritz Benjamin, Mehdiani, Arash, Rellecke, Philipp, Westenfeld, Ralf, Aubin, Hug, Boeken, Udo, Lichtenberg, Artur, Akhyari, Payam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300886/
https://www.ncbi.nlm.nih.gov/pubmed/35872893
http://dx.doi.org/10.3389/fcvm.2022.926389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300886/
https://www.ncbi.nlm.nih.gov/pubmed/35872893
http://dx.doi.org/10.3389/fcvm.2022.926389

Ejemplares similares